P. Stattin

870 total citations
17 papers, 512 citations indexed

About

P. Stattin is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, P. Stattin has authored 17 papers receiving a total of 512 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in P. Stattin's work include Prostate Cancer Treatment and Research (10 papers), Prostate Cancer Diagnosis and Treatment (7 papers) and Cancer, Lipids, and Metabolism (4 papers). P. Stattin is often cited by papers focused on Prostate Cancer Treatment and Research (10 papers), Prostate Cancer Diagnosis and Treatment (7 papers) and Cancer, Lipids, and Metabolism (4 papers). P. Stattin collaborates with scholars based in Sweden, United States and United Kingdom. P. Stattin's co-authors include Anders Bergh, P Westin, Jan‐Erik Damber, Mattias Johansson, G. Hallmans, Hans Garmo, Tanja Stocks, Annekatrin Lukanova, Sabina Rinaldi and Ulf‐Håkan Stenman and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, British Journal of Cancer and International Journal of Cancer.

In The Last Decade

P. Stattin

15 papers receiving 496 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Stattin Sweden 7 257 186 184 160 69 17 512
Nathan D. Seligson United States 13 165 0.6× 192 1.0× 213 1.2× 108 0.7× 27 0.4× 38 532
Danielle Crawley United Kingdom 12 146 0.6× 142 0.8× 112 0.6× 117 0.7× 26 0.4× 33 381
Betsy Higgins United States 11 518 2.0× 123 0.7× 203 1.1× 117 0.7× 94 1.4× 17 742
Cecilia Bosco United Kingdom 9 250 1.0× 102 0.5× 94 0.5× 113 0.7× 61 0.9× 23 543
Young Sun Lee United States 10 370 1.4× 125 0.7× 133 0.7× 111 0.7× 18 0.3× 17 580
Séverine Sarp Switzerland 9 76 0.3× 119 0.6× 196 1.1× 109 0.7× 28 0.4× 18 398
Kouki Ohtsuka Japan 13 273 1.1× 168 0.9× 243 1.3× 115 0.7× 33 0.5× 43 521
A. Celma Spain 13 530 2.1× 170 0.9× 98 0.5× 149 0.9× 22 0.3× 97 727
Noriyoshi Miura Japan 18 343 1.3× 212 1.1× 171 0.9× 119 0.7× 40 0.6× 70 757
Antonio Pazzola Italy 15 478 1.9× 146 0.8× 398 2.2× 114 0.7× 23 0.3× 43 767

Countries citing papers authored by P. Stattin

Since Specialization
Citations

This map shows the geographic impact of P. Stattin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Stattin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Stattin more than expected).

Fields of papers citing papers by P. Stattin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Stattin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Stattin. The network helps show where P. Stattin may publish in the future.

Co-authorship network of co-authors of P. Stattin

This figure shows the co-authorship network connecting the top 25 collaborators of P. Stattin. A scholar is included among the top collaborators of P. Stattin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Stattin. P. Stattin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Westerberg, Marcus, Hans Garmo, Jonas F. Ludvigsson, P. Stattin, & Rolf Gedeborg. (2025). Discriminative Ability of the Charlson Comorbidity Index for Long-Term Mortality in a General Population: Nationwide, Population-Based Study of 10 Million Adults in Sweden. Clinical Epidemiology. Volume 17. 983–993.
2.
Garmo, Hans, et al.. (2025). Incidence and prognostic implications of prostate-specific antigen persistence and relapse after radical prostatectomy: population-based study. JNCI Journal of the National Cancer Institute. 117(6). 1142–1150. 2 indexed citations
3.
Garmo, Hans, Kerri Beckmann, Ola Bratt, et al.. (2025). Prostate cancer characteristics in fathers and risk of early onset high‐risk prostate cancer in sons. International Journal of Cancer. 158(4). 977–983. 1 indexed citations
4.
Westerberg, Marcus, Lennart Holm, Hans Garmo, P. Stattin, & Rolf Gedeborg. (2025). Cohort Profile Update: The National Prostate Cancer Register of Sweden and PCBase. International Journal of Epidemiology. 54(6).
5.
6.
Ventimiglia, Eugenio, et al.. (2025). Radical Treatment for Prostate Cancer in Men With Limited Life Expectancy in Sweden. JAMA Network Open. 8(5). e258572–e258572. 1 indexed citations
7.
Robinson, David S., Hans Garmo, Mieke Van Hemelrijck, et al.. (2018). Androgen deprivation therapy for prostate cancer and risk of dementia. European Urology Supplements. 17(2). e1075–e1075. 5 indexed citations
8.
Loeb, Stacy, Yasin Folkvaljon, Dmitrii E. Makarov, et al.. (2014). 29 Active surveillance in the National Prostate Cancer Register (NPCR) of Sweden: Patterns of care and outcomes after 5 years of follow-up. European Urology Supplements. 13(1). e29–e29. 1 indexed citations
9.
Lissbrant, Ingela Franck, Hans Garmo, Anders Widmark, & P. Stattin. (2013). Population-based study on use of chemotherapy in men with castration resistant prostate cancer. Acta Oncologica. 52(8). 1593–1601. 41 indexed citations
10.
Grundmark, Birgitta, Hans Garmo, Björn Zethelius, et al.. (2012). Anti-androgen prescribing patterns, patient treatment adherence and influencing factors; results from the nationwide PCBaSe Sweden. European Journal of Clinical Pharmacology. 68(12). 1619–1630. 31 indexed citations
11.
Bjørge, Tone, A. Lukanova, S. Tretli, et al.. (2011). Metabolic risk factors and ovarian cancer in the Metabolic Syndrome and Cancer project. International Journal of Epidemiology. 40(6). 1667–1677. 40 indexed citations
12.
Adolfsson, Jan, Andreas Thorstenson, Ola Bratt, et al.. (2011). 1096 ABSOLUTE AND RELATIVE RISK OF FRACTURES IN PROSTATE CANCER PATIENTS: RESULTS FROM THE POPULATION-BASED PCBASE SWEDEN. European Urology Supplements. 10(2). 337–338. 1 indexed citations
13.
Holmström, B, Mattias Johansson, Anders Bergh, et al.. (2009). Prostate specific antigen for early detection of prostate cancer: longitudinal study. BMJ. 339(sep24 1). b3537–b3537. 94 indexed citations
14.
Hemelrijck, Mieke Van, Hans Garmo, Anna Bill‐Axelson, et al.. (2009). 1BA Increased cardiovascular morbidity and mortality following endocrine treatment for prostate cancer: an analysis in 30,642 men in PCBaSe Sweden. European Journal of Cancer Supplements. 7(3). 1–1. 2 indexed citations
15.
Stocks, Tanja, Annekatrin Lukanova, Mattias Johansson, et al.. (2007). Components of the metabolic syndrome and colorectal cancer risk; a prospective study. International Journal of Obesity. 32(2). 304–314. 130 indexed citations
16.
Stattin, P., P Westin, J‐E. Damber, & Anders Bergh. (1998). Short-term cellular effects induced by castration therapy in relation to clinical outcome in prostate cancer. British Journal of Cancer. 77(4). 670–675. 28 indexed citations
17.
Westin, P, P. Stattin, Jan‐Erik Damber, & Anders Bergh. (1995). Castration therapy rapidly induces apoptosis in a minority and decreases cell proliferation in a majority of human prostatic tumors.. PubMed. 146(6). 1368–75. 134 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nathan D. Seligson Breakdown of academic impact, for papers by Danielle Crawley Breakdown of academic impact, for papers by Betsy Higgins Breakdown of academic impact, for papers by Cecilia Bosco Breakdown of academic impact, for papers by Young Sun Lee Breakdown of academic impact, for papers by Séverine Sarp Breakdown of academic impact, for papers by Kouki Ohtsuka Breakdown of academic impact, for papers by A. Celma Breakdown of academic impact, for papers by Noriyoshi Miura Breakdown of academic impact, for papers by Antonio Pazzola
Rankless by CCL
2026